Skip to content

Clinical trials

Completed Pancreatic Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Status: Completed Country / region: Australia Clear all

50 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20052
20062
20084
20091
20101
20114
20121
20131
20143
20152
20163
20176
20185
20191
20204
20212
20223
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed50

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene4
Eli Lilly and Company4
Pfizer4
Hoffmann-La Roche3
AstraZeneca2
Bristol-Myers Squibb2
OncoMed Pharmaceuticals, Inc.2
Panbela Therapeutics, Inc.2
AmMax Bio, Inc.1
Arbele Pty Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms50
Neoplasms11
Carcinoma, Non-Small-Cell Lung8
Neoplasm Metastasis8
Colorectal Neoplasms7
Triple Negative Breast Neoplasms7
Cholangiocarcinoma5
Ovarian Neoplasms4
Biliary Tract Neoplasms3
Breast Neoplasms3

Trials

Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.